Rowlett, J. ., NW, P. . , Jr, & Bardo, M. . (1991). Catalepsy produced by striatal microinjections of the D1 dopamine receptor antagonist SCH 23390 in neonatal rats. Pharmacology, Biochemistry, and Behavior, 40(4), 829-34. https://doi.org/10.1016/0091-3057(91)90093-h

Lauderback, C. ., Harris-White, M. ., Wang, Y. ., NW, P. . , Jr, Carney, J. ., & Butterfield, D. . Amyloid beta-peptide inhibits Na+-dependent glutamate uptake. Life Sciences, 65(18-19), 1977-81. https://doi.org/10.1016/s0024-3205(99)00459-2 (Original work published 1999)

Butterfield, D. ., Howard, B. ., Yatin, S. ., Koppal, T. ., Drake, J. ., Hensley, K. ., … Carney, J. . Elevated oxidative stress in models of normal brain aging and Alzheimer’s disease. Life Sciences, 65(18-19), 1883-92. https://doi.org/10.1016/s0024-3205(99)00442-7 (Original work published 1999)

Harris, M. ., Wang, Y. ., NW, P. . , Jr, Hensley, K. ., Butterfield, D. ., & Carney, J. . (1996). Amyloid beta peptide (25-35) inhibits Na+-dependent glutamate uptake in rat hippocampal astrocyte cultures. Journal of Neurochemistry, 67(1), 277-86. https://doi.org/10.1046/j.1471-4159.1996.67010277.x

Harris, M. ., Carney, J. ., Cole, P. ., Hensley, K. ., Howard, B. ., Martin, L. ., … Butterfield, D. . (1995). beta-Amyloid peptide-derived, oxygen-dependent free radicals inhibit glutamate uptake in cultured astrocytes: implications for Alzheimer’s disease. Neuroreport, 6(14), 1875-9. https://doi.org/10.1097/00001756-199510020-00013 (Original work published 1995)